Jazz Pharmaceuticals
JAZZ
JAZZ
500 hedge funds and large institutions have $7.99B invested in Jazz Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 160 increasing their positions, 201 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0% more funds holding
Funds holding: 500 → 500 (0)
2.11% less ownership
Funds ownership: 102.09% → 99.98% (-2.1%)
20% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 201
Holders
500
Holding in Top 10
12
Calls
$130M
Puts
$23.7M
Top Buyers
| 1 | +$136M | |
| 2 | +$44.8M | |
| 3 | +$35.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.4M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$27.9M |
Top Sellers
| 1 | -$84M | |
| 2 | -$47.1M | |
| 3 | -$34.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$30M |
| 5 |
Morgan Stanley
New York
|
-$29.8M |
